TrialBMC infectious diseases2021

Safety and efficacy of hydroxychloroquine for treatment of non-severe COVID-19 among adults in Uganda: a randomized open label phase II clinical trial.

Pauline Byakika-Kibwika et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.